Učitavanje...
Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
Despite decades of effort to develop effective therapy and to identify promising new drugs, prostate cancer is lethal once it progresses to castration-resistant disease. Studies show mis-regulation of multiple pathways in castration-resistant prostate cancer (CRPC), reflecting the heterogeneity of t...
Spremljeno u:
| Izdano u: | PLoS One |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4624871/ https://ncbi.nlm.nih.gov/pubmed/26509262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141589 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|